KalVista Pharmaceuticals
KALV
KALV
89 hedge funds and large institutions have $364M invested in KalVista Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 28 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
42% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 19
Holders
89
Holding in Top 10
2
Calls
$1.66M
Puts
–
Top Buyers
| 1 | +$9.55M | |
| 2 | +$6.81M | |
| 3 | +$5.28M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$3.39M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
+$2.65M |
Top Sellers
| 1 | -$17.3M | |
| 2 | -$6.85M | |
| 3 | -$5.08M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$4.18M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$1.84M |